SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting
An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for ...
Read moreAn additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for ...
Read moreZÜRICH, Switzerland, April 05, 2024 (GLOBE NEWSWIRE) -- CDR-Life Inc. today announced the presentation of preclinical data demonstrating the promising ...
Read moreQ3W schedule of CRB-701 (SYS6002) demonstrates a 43% ORR and 71% DCR at predicted therapeutically relevant dosesAll assessable nectin-4 positive ...
Read moreEnrolled first PH-ILD patient in the open-label ASCENT study of YUTREPIAConfirmed with FDA that a single pivotal efficacy trial with ...
Read moreThe SERP Scraper API, developed in collaboration with a team of elite intelligence researchers, available now for businesses at www.netnut.io ...
Read more09 Nov 2023 - The International Olympic Committee (IOC) has recently been faced with a number of fake news posts targeting ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.